[Relationship between elevated plasma endothelin-1 level and renal function in patients with diabetic nephropathy]

Area of Science:

• Endocrinology
• Nephrology
• Cardiovascular Research

Context:

• Diabetic nephropathy is a major complication of diabetes mellitus.
• Endothelin-1 (ET-1) is a potent vasoconstrictor peptide implicated in cardiovascular and renal diseases.
• Understanding ET-1's role in diabetic nephropathy is crucial for developing targeted therapies.

Purpose:

• To investigate the association between plasma endothelin-1 (ET-1) levels and the stages of diabetic nephropathy.
• To correlate ET-1 levels with clinical parameters of renal function and glycemic control.

Summary:

• Plasma ET-1 levels were measured in normal subjects and patients across various stages of diabetic nephropathy (DM, IDN, ODN, DNa, DNu).
• Significantly elevated ET-1 levels were observed in all stages of nephropathy compared to normal subjects, with progressive increases correlating with disease severity.
• ET-1 levels showed positive correlations with HbA1c, blood pressure, blood urea nitrogen, serum creatinine, and urinary albumin excretion rate (uAER), and a negative correlation with glomerular filtration rate.

Impact:

• This study demonstrates a strong relationship between elevated plasma ET-1 and the progression of renal impairment in diabetic nephropathy.
• The findings highlight ET-1 as a potential biomarker for disease severity and progression.
• Targeting ET-1 pathways may offer a therapeutic strategy for managing diabetic nephropathy.